The postdoctoral research training program in Endocrinology and Diabetes at the Massachusetts General Hospital is intended to provide intensive research experience in basic or clinical investigation, complemented by didactic research training in basic sciences pertinent to endocrinology and diabetes. The trainees are primarily M.D.'s and M.D./Ph.D.'s who desire a career in investigative endocrinology and academic medicine, as well as Ph.D.'s who want further research training. The trainees are selected from a large applicant pool on the basis of prior academic and/or research achievement, and evidence of strong commitment to a career in biomedical investigation. The Program director (J. Avruch) is a senior academician/endocrine investigator who governs in conjunction with a committee of experienced endocrine scientists (Habener, Kronenberg, Crowley, Neer, Freeman and Klibanski). The training faculty consists of 46 active, well-funded scientists, whose interests range broadly across the subdisciplines of endocrinology, and from clinical investigation to the regulation of gene expression, protein structural analysis, transmembrane signaling mechanisms, etc. The trainees are supervised closely by a primary faculty mentor, and interact extensively with junior faculty, who often serve as secondary mentors. A carefully evolved and extensive program of didactic sessions complements the research activity. The training period is 2-3 years but may include several years additional experience at junior faculty status, so as to permit consolidation of skills and maximal competitiveness for independent support. The productivity of past trainees during training has been very high overall, as judged by the number and quality of trainee publications. Among the program graduates since 1990 supported by this grant, the majority remain in academia and a substantial number are in the biotechnology/pharmaceutical industry. Among those in academia, about one quarter have achieved independent support equivalent to an RO-1 and nearly one third have achieved transitional independent support, a usual precursor to RO-1 support. The facilities at the MGH are extensive, including an active GCRC, an Institutional Clinical Research Support Program, access to a very large base of endocrine/diabetes patients, and over 40,000 square feet of fully equipped modern laboratory dedicated to our training faculty. The institutional training grant represents the central stabilizing financial element in this program, and is especially critical in enabling M.D. trainees to achieve careers in biomedical investigation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007028-35S1
Application #
7879680
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
35
Fiscal Year
2009
Total Cost
$28,270
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Rosenbaum, Matthew W; Gigliotti, Benjamin J; Pai, Sara I et al. (2018) PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma. Endocr Pathol 29:59-67
Gogia, Shawnbir; Coromilas, Alexandra; Regan, Susan et al. (2018) Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study. J Acquir Immune Defic Syndr 79:e39-e41
Cheru, Lediya T; Park, Elli A; Saylor, Charles F et al. (2018) I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV. Open Forum Infect Dis 5:ofy288
Chan, Yee-Ming; Lippincott, Margaret F; Kusa, Temitope O et al. (2018) Divergent responses to kisspeptin in children with delayed puberty. JCI Insight 3:
Fourman, Lindsay T; Czerwonka, Natalia; Shaikh, Sofia D et al. (2018) Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS 32:927-932
Karaca, Anara; Malladi, Vijayram Reddy; Zhu, Yan et al. (2018) Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth. Bone 110:230-237
Devlin, M J; Robbins, A; Cosman, M N et al. (2018) Differential effects of high fat diet and diet-induced obesity on skeletal acquisition in female C57BL/6J vs. FVB/NJ Mice. Bone Rep 8:204-214
Dichtel, Laura E; Bjerre, Mette; Schorr, Melanie et al. (2018) The effect of growth hormone on bioactive IGF in overweight/obese women. Growth Horm IGF Res 40:20-27
Cox, Kimberly H; Oliveira, Luciana M B; Plummer, Lacey et al. (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338-350
Yang, Xuehui; Gong, Yan; He, Qing et al. (2018) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem 119:3267-3279

Showing the most recent 10 out of 169 publications